Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: An eastern cooperative oncology group study (E 6397)

Journal of Clinical Oncology

Volumn 23, Issue 34, 2005, Pages 8870-8876

  Manon, Rafael ^a   O'Neill, Anne ^a   Knisely, Jonathan ^a   Werner Wasik, Maria ^a   Lazarus, Hillard M ^a   Wagner, Henry ^a   Gilbert, Mark ^a   Mehta, Minesh ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CORTICOSTEROID; DEXAMETHASONE;

ARTICLE; BRAIN METASTASIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; KIDNEY CARCINOMA; MALE; MELANOMA; PRIORITY JOURNAL; RADIOSURGERY; SARCOMA; TOXICITY; TREATMENT FAILURE; TUMOR VOLUME; ADULT; BRAIN; BRAIN TUMOR; CANCER STAGING; FOLLOW UP; KIDNEY TUMOR; METASTASIS; METHODOLOGY; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY; PHASE 2 CLINICAL TRIAL; PHYSIOLOGY; PROSPECTIVE STUDY; SURVIVAL; SURVIVAL RATE; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; BRAIN; BRAIN NEOPLASMS; CARCINOMA, RENAL CELL; COGNITION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; MALE; MELANOMA; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOSURGERY; SARCOMA; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 33644833432     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.01.8747     Document Type: Article

References (29)

1. Clouston PD, DeAngelis LM, Posner JB: The spectrum of neurological disease in patients with systemic cancer. Ann Neurol 31:268-273, 1992
2. Johnson JD, Young B: Demographics of brain metastasis. Neurosurg Clin N Am 7:337-344, 1996
3. Posner JB: Management of brain metastases. Rev Neurol 148:477-487, 1992
4. Patchell RA: The management of brain metastases. Cancer Treat Rev 29:533-540, 2003
5. Wen PY, Loeffler JS: Management of brain metastases. Oncology (Huntington) 13:941-954, 1999
6. Mehta MP, Shapiro WR, Glantz MJ, et al: Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: Centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points. J Clin Oncol 20:3445-3453, 2002
7. Cairncross JG, Kim JH, Posner JB: Radiation therapy for brain metastases. Ann Neurol 7:529-541, 1980
8. Patchell RA, Tibbs PA, Regine WF, et al: Postoperative radiotherapy in the treatment of single metastases to the brain: A randomized trial. JAMA 280:1485-1489, 1998
9. Andrews DW, Scott CB, Sperduto PW, et al: Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508. Lancet 363:1665-1672, 2004
10. Kondziolka D, Patel A, Lunstord LD, et al: Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 45:427-434, 1999
11. Pirzkall A, Debus J, Lohr F, et al: Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol 16:3563-3569, 1998
12. Sneed PK, Suh JH, Goetsch SJ, et al: A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 53:519-526, 2002
13. Wronski M, Maor MH, Davis BJ, et al: External radiation of brain metastases from renal carcinoma: A retrospective study of 119 patients from the M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys 37:753-759, 1997
14. Mori Y, Kondziolka D, Flickinger JC, et al: Stereotactic radiosurgery for brain metastasis from renal cell carcinoma. Cancer 83:344-353, 1998
15. Mori Y, Kondziolka D, Flickinger JC, et al: Stereotactic radiosurgery for cerebral metastatic melanoma: Factors affecting local disease control and survival. Int J Radiat Oncol Biol Phys 42:581-589, 1998
16. Alexander E, Moriarty TM, Davis RB, et al: Stereotactic radiosurgery for the definitive, non-invasive treatment of brain metastases. J Natl Cancer Inst 87:34-40, 1995
17. Flickinger JC, Kondziolka D, Lunsford LD, et al: A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 28:797-802, 1994
18. Shaw E, Scott C, Souhami L, et al: Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: Final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 47:291-298, 2000
19. Murray KJ, Scott C, Zachariah, et al: Importance of the mini mental-status examination in the treatment of patients with brain metastases: A report from the Radiation Therapy Oncology Group Protocol 9104. Int J Radiat Oncol Biol Phys 48:59-64, 2000
20. Cox DR, Snell EJ: Analysis of Binary Data (ed 2). London, United Kingdom, Chapman and Hall, 1989
21. Kalbfeisch JD, Prentice RI: The Statistical Analysis of Failure Time Data. New York, NY, Wiley, 1980
22. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
23. Aoyama H, Shirato H, Nakagawa K et al: Interim report of JROSG99-1 Multi-institutional prospective randomized trial comparing SRS alone vs. WBI+SRS for 1-4 brain metastases. J Clin Oncol 22:108, 2004 (suppl; abstr 1506)
24. Sneed PK, Lamborn KR, Forstner JM, et al: Radiosurgery for brain metastases: Is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys 43:549-558, 1999
25. DeAngelis LM, Delattre JY, Posner JB: Radiation-induced dementia in patients cured of brain metastases. Neurology 39:789-796, 1989
26. Regine WF, Huhn JL, Patchell RA, et al: Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: Results and implications. Int J Radiat Oncol Biol Phys 52:333-338, 2002
27. Regine WF, Scott C, Murray K, et al: Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: An analysis from Radiation Therapy Oncology Group Study 91-04. Int J Radiat Oncol Biol Phys 51:711-717, 2001
28. Meyers CA, Smith JA, Bezjak A, et al: Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: Results of a randomized phase III trial. J Clin Oncol 22:157-165, 2004
29. Mehta MP, Rodrigus P, Terhaard CH, et al: Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol 21:2529-2536, 2003